The latest development in breast cancer treatment brings hope and progress. On November 16, 2023, the Food and Drug Administration (FDA) approved capivasertib, in combination with fulvestrant, for adult patients battling hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative locally advanced or metastatic breast cancer. This approval marks a significant step forward for …
Breast Cancer
Explore comprehensive insights on breast cancer, its prevention, diagnosis, and treatment options on MedOnCmd’s dedicated category. Stay informed and empowered in your breast health journey
Breast cancer is a significant health concern affecting women worldwide. With October being Breast Cancer Awareness Month, it is crucial for women to understand the importance of regular breast cancer screenings. Regular screenings, including mammograms and self-exams, play a vital role in detecting breast cancer early, improving treatment outcomes, and saving lives. In this article, …
A breast cancer diagnosis is a life-altering event that extends its impact far beyond the physical realm. It sends ripples through the emotional and psychological landscape, affecting not only the patient but also their families. In recognition of Breast Cancer Awareness Month, let’s delve into the emotional journey that often accompanies a breast cancer diagnosis …
Breast cancer, a formidable adversary, affects millions of lives worldwide each year. In our quest to combat this disease, knowledge is the most potent weapon we have. Breast Cancer Awareness Month is the ideal time to explore the intricacies of breast cancer risk factors, from the genetic underpinnings to lifestyle choices that can influence your …